World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 12 February 2013
Main ID:  ISRCTN94738550
Date of registration: 19/10/2007
Primary sponsor: Chinese University of Hong Kong (Hong Kong)
Public title: Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial N/A
Scientific title:
Date of first enrolment: Jan 1 2005
Target sample size: 783
Recruitment status: Completed/Not recruiting
URL:  http://isrctn.org/ISRCTN94738550
Study type:  Interventional
Study design:  Prospective, double-blind, randomised controlled trial  
Countries of recruitment
Hong Kong
Contacts
Name: Colin  Graham
Address:  Trauma and Emergency Centre Prince of Wales Hospital NT Shatin Hong Kong
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: All patients greater than 16 years presenting to the Emergency Department (ED) with isolated soft tissue injury without significant fracture between 9 am to 5 pm, Monday to Friday.
Exclusion criteria: Patients will be excluded if there is:
1. A history of peptic ulceration or haemorrhage
2. Recent anticoagulation
3. Pregnancy
4. Adverse reaction to paracetamol or ibuprofen
5. Renal or cardiac failure
6. Hepatic problems
7. Rectal bleeding
8. Chronic Non-Steriodal Anti-Inflammatory Drug (NSAID) consumption
9. Asthma
10. Chronic obstructive pulmonary disease
11. Chronic pain syndromes
12. Prior treatment with analgesia for the same injury

Patients will also be excluded if they have a physical, visual or cognitive impairment making use of the visual analogue scale unreliable.


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Soft Tissue Injuries
Intervention(s)
Arm 1: Paracetamol 1 g four times daily (qid) and ibuprofen placebo equivalent to 400 mg three times daily (tid)
Arm 2: Paracetamol placebo equivalent to 1 g qid and ibuprofen 400 mg tid
Arm 3: Paracetamol 1 g qid and ibuprofen 400 mg tid

Treatment will continue for three days, follow-up will continue for 30 days.
Primary Outcome(s)
Analgesic efficacy both at rest and with movement at 72 hours.
Secondary Outcome(s)
1. Presence, frequency and duration of adverse effects at 30 days
2. Cost-effectiveness analysis at 30 days
3. Patient satisfaction with analgesia at 30 days
Secondary ID(s)
HKCEM06-07/DG2041095
Source(s) of Monetary Support
1. Chinese University of Hong Kong (Hong Kong) (Direct Grant: 2041095) 2. Hong Kong College of Emergency Medicine (Hong Kong) (Grant: 2006-07)
Secondary Sponsor(s)
N/A
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history